Option Care Health director proposes $208K share sale

The shares are listed as issuer stock awards acquired in three transactions from May 14 through May 17, 2026.

Available on EDGAR 11/10/2026 - 01:38 PM EST Accepted by SEC EDGAR 11/10/2026 - 01:37 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Option Care Health, Inc. director Robert C Pate reported a notice covering the proposed sale of 6,492 common shares, with an aggregate market value of $207,750 and an approximate sale date of November 10, 2026. The notice lists 149,799,704 shares outstanding. Pate acquired the shares from the issuer as stock awards: 1,678 shares on May 14, 2026, 1,775 shares on May 15, 2026, and 3,039 shares on May 17, 2026.

Key Figures

Shares proposed for sale: 6,492 common shares Aggregate Market Value: $207,750 Shares outstanding: 149,799,704 shares +3 more

6 metrics

Shares proposed for sale 6,492 common shares Approximate sale date: November 10, 2026

Aggregate Market Value $207,750 Shares proposed for sale

Shares outstanding 149,799,704 shares Common shares

Stock Award 1,678 shares Acquired May 14, 2026

Stock Award 1,775 shares Acquired May 15, 2026

Stock Award 3,039 shares Acquired May 17, 2026

Key Terms

Aggregate Market Value, Stock Award, Approximate Date of Sale

3 terms

Aggregate Market Value financial

"Aggregate Market Value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Stock Award financial

"Nature of Acquisition Transaction: Stock Award"

Approximate Date of Sale regulatory

"Approximate Date of Sale"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OPCH shares did director Robert C Pate report for sale?

The notice lists 6,492 common shares for proposed sale, with an aggregate market value of $207,750 and an approximate sale date of November 10, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001641406
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Option Care Health, Inc.
SEC File Number	001-11993
Address of Issuer	3000 Lakeside Drive Suite 300 N Bannockburn ILLINOIS 60015
Phone	312-9402443
Name of Person for Whose Account the Securities are To Be Sold	Robert C Pate
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 1033 Skokie Blvd. Suite 500 Northbrook IL 60062	6492	207750	149799704	11/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/14/2026	Stock Award	Issuer			1678	05/14/2026	Compensation
Common	05/15/2026	Stock Award	Issuer			1775	05/15/2026	Compensation
Common	05/17/2026	Stock Award	Issuer			3039	05/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	11/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Robert C Pate
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)